Regenicin - Dividend History | RGIN
Historical dividend payout and yield for Regenicin (RGIN) since 1971. The current TTM dividend payout for Regenicin (RGIN) as of December 31, 1969 is $0.00. The current dividend yield for Regenicin as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.001B |
$0.000B |
|
Regenicin, Inc is a development stage biotechnology company primarily focused on the development of regenerative cell therapies to restore the health of damaged tissues and organs. The Company's product candidate includes PermaDerm that uses the patient's own skin cells to generate living, tissue-engineered skin for the treatment of chronic burns and wounds. The candidate uses biomedical polymer to act as a connective agent in the skin generation process. The Company's prime focus is development of therapeutics in the areas of diabetes, chronic wounds, including ulcers, adult stem cell therapies and reconstructive surgery applications. Regenicin, Inc is headquartered in New York, New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
